Skip to main content

Table 1 Characteristic of subjects (mean ± SD)

From: Transcutaneous Neuromodulation improved inflammation and sympathovagal ratio in patients with primary biliary ssscholangitis and inadequate response to Ursodeoxycholic acid: a pilot study

  male/female age height (cm) weight (kg) BMI
PBC 2/8 52.10 ± 11.10 164.30 ± 6.88 66.15 ± 10.15 24.41 ± 2.61
Control 3/7 47.20 ± 8.60 166.90 ± 8.63 66.10 ± 7.92 23.73 ± 1.87
  1. P1 is PBC patients (pretreatment) compared with controls, *p < 0.05.